Regression of colorectal adenomas with intravenous cytotoxic chemotherapy in a patient with familial adenomatous polyposis [21]

Journal of Clinical Oncology

Volumn 23, Issue 25, 2005, Pages 6278-6280

  Jones, Douglas H ^a   Silberstein, Peter T ^a   Lynch, Henry ^a   Ternet, Charles ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC; CARCINOEMBRYONIC ANTIGEN; CYTOTOXIC AGENT; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; IRINOTECAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

ADENOMATOUS POLYP; ADULT; AMENORRHEA; ANAMNESIS; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SIZE; CASE REPORT; COLONOSCOPY; COLORECTAL ADENOMA; ECHOGRAPHY; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; FAMILIAL DISEASE; FEMALE; GASTRITIS; HEMATOCRIT; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; LETTER; LIVER BIOPSY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; ADENOMA; COLON POLYPOSIS; COLON TUMOR; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 24944588840     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.00.0570     Document Type: Letter

References (15)

1. Jemal A, Murray T, Samuels A, et al: Cancer statistics, 2003. CA Cancer J Clin 53:5-26, 2003
2. Burt RW, DiSario JA, Cannon-Albright L: Genetics of colon cancer: Impact of inheritance on colon cancer risk. Annu Rev Med 46:371-379, 1995
3. Wennstrom J, Pierce ER, McKusick VA: Hereditary benign and malignant lesions in the large bowel. Cancer 34:850-857, 1974 (suppl 3)
4. Petersen GM, Slack J, Nakamura Y: Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 100:1658-1664, 1991
5. Laurent-Puig P, Beroud C, Soussi T: APC gene: Database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 26:269-270, 1998
6. Steinbach G, Lynch PM, Phillips RKS, et al: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946-1952, 2000
7. Baron JA, Cole BF, Sandler RS, et al: A randomized trial to aspirin to prevent colorectal adenomas. N Engl J Med 348:891-899, 2003
8. Lynch HT, Thorson AG, Smyrk T: Rectal cancer after prolonged sulindac chemoprevention: A case report. Cancer 75:936-938, 1995
9. Hawk ET, Asad U, Viner JL: Colorectal cancer prevention: An overview of the science. Gastroenterology 28:1423-1447, 2004
10. Janne PA, Mayer RJ: Chemoprevention of colorectal cancer. N Engl J Med 342:1960-1968, 2000
11. Watanabe H, Enjoji M, Yao T, et al: Gastric lesions in familial adenomatosis coli: Their incidence and histologic analysis. Hum Pathol 9:269-283, 1978
12. Alexander JR, Andreas JM, Buchi K, et al: High prevalence of adenomatous polyps of duodenal papilla in familial adenomatous polyposis. Dig Dis Sci 34:167-170, 1989
13. Offerhous GJ, Giardiello FM, Krush AJ, et al: The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102:1980-1982, 1992
14. Hideaki I, Mitsuo I, Ryuichi M, et al: Local chemotherapy for rectal polyposis: Intraluminal administration of 5-fluorouracil for postoperative control of adenomas in the retained rectum in familial polyposis. J Clin Gastroenterol 11:645-649, 1989
15. Bookman ID, Redston MS, Greenberg GR: Successful treatment of cap polyposis with infliximab. Gastroenterology 126:1868-1871, 2004